Press releases

Press releases

Results

No results found. Please try using different filter option(s).

In the media

24 Oct 2021

Remise des infrastructures médicales à Kwilu et Maindombe

RTNC

In the media

23 Oct 2021

Moonshot is the spanner in the Covid-19 works the country needs

The Times

Publications

21 Oct 2021

InfoLEISH 5^th edition

Stories

20 Oct 2021

‘We are building a generation of scientists who will transform research in Africa’

Scientific articles

20 Oct 2021

Ravidasvir: equitable access through an alternative drug development pathway

The Lancet Global Health

In the media

17 Oct 2021

Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again

CNN

In the media

15 Oct 2021

Renforcement des capacités et amélioration des infrastructures des prestations de services THA au niveau périphérique

RTNC

In the media

14 Oct 2021

Molnupiravir, el antiviral oral contra el COVID-19 que logró reducir un 50% el riesgo en casos graves

Infobae

Scientific articles

13 Oct 2021

Onchocerciasis drug development: from preclinical models to humans

Parasitology Research

In the media

12 Oct 2021

Rush to buy Merck’s Covid pill risks leaving poor countries behind

Bloomberg

In the media

12 Oct 2021

‘Therapeutics nationalism’? Poor at risk of being left behind as rich buy up new Covid drug

Common Dreams

In the media

8 Oct 2021

Equitable access to Covid-19 diagnostics and therapeutics is key to ending the pandemic

Peoples Dispatch

Scientific articles

8 Oct 2021

Recommendations for screening and diagnosis of Chagas disease in the United States

The Journal of Infectious Diseases

In the media

8 Oct 2021

Merck’s experimental Covid pill should be accompanied by other treatments – expert

Bloomberg

In the media

8 Oct 2021

How antiviral pill molnupiravir shot ahead in the COVID drug hunt

Nature

News Translations

6 Oct 2021

Projets de l’année 2021 de DNDi : des partenaires et des collègues récompensés pour le travail accompli dans la mise au point de nouveaux traitements de la leishmaniose viscérale et de la maladie du sommeil

Loading...

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

Get in touch

Support us

Work with us